Literature DB >> 17825122

The DEBIT trial: an intervention to reduce antipsychotic polypharmacy prescribing in adult psychiatry wards - a cluster randomized controlled trial.

A Thompson1, S A Sullivan, M Barley, S O Strange, L Moore, P Rogers, A Sipos, G Harrison.   

Abstract

BACKGROUND: Clinical guidelines advise against prescribing more than one antipsychotic with limited exceptions. Despite this, surveys continue to report high antipsychotic polypharmacy rates. The aim of the study was to investigate the effectiveness of a multi-faceted intervention in reducing prescribing of antipsychotic polypharmacy on general adult psychiatry wards, compared with guidelines alone.
METHOD: A pragmatic cluster randomized controlled trial recruited 19 adult psychiatric units (clusters) from the South West of England. Participants were all ward doctors and nurses. The multi-faceted intervention comprised: an educational/CBT workbook; an educational visit to consultants; and a reminder system on medication charts.
RESULTS: The odds of being prescribed antipsychotic polypharmacy in those patients prescribed antipsychotic medication was significantly lower in the intervention than control group when adjusted for confounders (OR 0.43, 95% CI 0.21-0.90, p=0.028). There was considerable between-unit variation in polypharmacy rates and in the change in rates between baseline and follow-up (5 months after baseline).
CONCLUSION: The intervention reduced levels of polypharmacy prescribing compared to guidelines alone although the effect size was relatively modest. Further work is needed to elicit the factors that were active in changing prescribing behaviour.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825122     DOI: 10.1017/S003329170700147X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  21 in total

1.  Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme.

Authors:  Shubhra Mace; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2015-02

Review 2.  A systematic review of educational interventions to change behaviour of prescribers in hospital settings, with a particular emphasis on new prescribers.

Authors:  Nicola Brennan; Karen Mattick
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 3.  Implementation of treatment guidelines for specialist mental health care.

Authors:  Irene Bighelli; Giovanni Ostuzzi; Francesca Girlanda; Andrea Cipriani; Thomas Becker; Markus Koesters; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

4.  National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Authors:  Jonathan S Comer; Mark Olfson; Ramin Mojtabai
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

Review 5.  Antipsychotic polypharmacy in schizophrenia: benefits and risks.

Authors:  Thomas R E Barnes; Carol Paton
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

6.  Effect of Peer Comparison Letters for High-Volume Primary Care Prescribers of Quetiapine in Older and Disabled Adults: A Randomized Clinical Trial.

Authors:  Adam Sacarny; Michael L Barnett; Jackson Le; Frank Tetkoski; David Yokum; Shantanu Agrawal
Journal:  JAMA Psychiatry       Date:  2018-10-01       Impact factor: 21.596

7.  Factors associated with non evidence-based prescribing of antipsychotics.

Authors:  Anne Connolly; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

8.  Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.

Authors:  Taishiro Kishimoto; Koichiro Watanabe; Hiroyuki Uchida; Masaru Mimura; John M Kane; Christoph U Correll
Journal:  Psychiatry Res       Date:  2013-04-18       Impact factor: 3.222

Review 9.  A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health.

Authors:  Tom E Richardson; Claire L O'Reilly; Timothy F Chen
Journal:  Int J Clin Pharm       Date:  2013-12-04

10.  Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.

Authors:  Robert O Cotes; David R Goldsmith; Sarah L Kopelovich; Cathy A Lally; Benjamin G Druss
Journal:  Community Ment Health J       Date:  2017-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.